MA53378A - Procédé d'utilisation d'un co-agoniste de gip/glp1 contre le diabète - Google Patents

Procédé d'utilisation d'un co-agoniste de gip/glp1 contre le diabète

Info

Publication number
MA53378A
MA53378A MA053378A MA53378A MA53378A MA 53378 A MA53378 A MA 53378A MA 053378 A MA053378 A MA 053378A MA 53378 A MA53378 A MA 53378A MA 53378 A MA53378 A MA 53378A
Authority
MA
Morocco
Prior art keywords
glp1
gip
against diabetes
agonist against
agonist
Prior art date
Application number
MA053378A
Other languages
English (en)
Inventor
Jorge Alsina-Fernandez
Over Cabrera
Tamer Coskun
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of MA53378A publication Critical patent/MA53378A/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/26Glucagons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
MA053378A 2018-07-23 2019-07-22 Procédé d'utilisation d'un co-agoniste de gip/glp1 contre le diabète MA53378A (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862702180P 2018-07-23 2018-07-23
US201862730562P 2018-09-13 2018-09-13
US201862740640P 2018-10-03 2018-10-03

Publications (1)

Publication Number Publication Date
MA53378A true MA53378A (fr) 2021-06-02

Family

ID=67544389

Family Applications (1)

Application Number Title Priority Date Filing Date
MA053378A MA53378A (fr) 2018-07-23 2019-07-22 Procédé d'utilisation d'un co-agoniste de gip/glp1 contre le diabète

Country Status (13)

Country Link
US (1) US20230293638A1 (fr)
EP (1) EP3826662A1 (fr)
JP (3) JP2021530544A (fr)
KR (1) KR20210024081A (fr)
CN (1) CN112469431A (fr)
AU (1) AU2019309798A1 (fr)
BR (1) BR112020026020A2 (fr)
CA (1) CA3107108A1 (fr)
IL (2) IL308674A (fr)
MA (1) MA53378A (fr)
MX (1) MX2021000792A (fr)
SG (1) SG11202100116TA (fr)
WO (1) WO2020023388A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202216746A (zh) 2020-06-22 2022-05-01 印度商太陽製藥工業有限公司 長效型glp-1/gip雙重促效劑
IL299701A (en) 2020-07-22 2023-03-01 Novo Nordisk As GLP-1 and GIP receptor co-agonists suitable for oral administration
IL301109A (en) 2020-10-17 2023-05-01 Sun Pharmaceutical Ind Ltd Dual GLP-1/GIP agonists
CA3208873A1 (fr) * 2021-02-17 2022-08-25 Mathijs Christiaan Michael BUNCK Procedes therapeutiques agonistes doubles gip/glp1
TW202330584A (zh) 2022-01-20 2023-08-01 丹麥商諾佛 儂迪克股份有限公司 前藥及其用途
CN116854805B (zh) * 2023-09-05 2023-12-15 杭州湃肽生化科技有限公司 替尔泊肽的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112013029062A2 (pt) * 2011-05-13 2016-11-29 Sanofi Aventis Deutschland lixisenatida e metformina para o tratamento de diabetes tipo 2
NZ702333A (en) 2012-05-03 2017-06-30 Zealand Pharma As Gip-glp-1 dual agonist compounds and methods
EP3033355A1 (fr) * 2013-08-16 2016-06-22 Medimmune Limited Agonistes doubles de récepteur de gip et glp-1 pour le traitement du diabète
JOP20200119A1 (ar) * 2015-01-09 2017-06-16 Lilly Co Eli مركبات مساعد مشترك من gip وglp-1
US20170112897A1 (en) * 2015-10-23 2017-04-27 Cedars-Sinai Medical Center Methods for treating brain insulin resistance
TWI622596B (zh) * 2015-10-26 2018-05-01 美國禮來大藥廠 升糖素受體促效劑
MX2021000793A (es) * 2018-07-23 2021-04-12 Lilly Co Eli Compuestos coagonistas de gip/glp1.

Also Published As

Publication number Publication date
CN112469431A (zh) 2021-03-09
EP3826662A1 (fr) 2021-06-02
JP2022177118A (ja) 2022-11-30
JP2024056852A (ja) 2024-04-23
SG11202100116TA (en) 2021-02-25
IL280159B2 (en) 2024-05-01
IL308674A (en) 2024-01-01
CA3107108A1 (fr) 2020-01-30
US20230293638A1 (en) 2023-09-21
WO2020023388A1 (fr) 2020-01-30
IL280159B1 (en) 2024-01-01
JP2021530544A (ja) 2021-11-11
IL280159A (en) 2021-03-01
BR112020026020A2 (pt) 2021-03-23
MX2021000792A (es) 2021-06-15
KR20210024081A (ko) 2021-03-04
AU2019309798A1 (en) 2021-02-11

Similar Documents

Publication Publication Date Title
MA53378A (fr) Procédé d'utilisation d'un co-agoniste de gip/glp1 contre le diabète
IL279827A (en) GIP/GLP1 co-agonist compounds
TWI799680B (zh) 製備gip/glp1雙重促效劑之方法
MA53390A (fr) Procédés d'utilisation d'un co-agoniste de gip/glp1 pour une thérapie
EP3781458C0 (fr) Procédé de détermination du rayon d'une courbe
GB201811539D0 (en) Fabrication process for a/m/x materials
DK3870405T3 (da) Apparat til bearbejdning af et arbejdsemne
GB201805954D0 (en) A method
PL3537496T3 (pl) Pojemnik baterii dla baterii
DK3455340T3 (da) Apparat til inkubation af et biologisk materiale
ITUB20153933A1 (it) Apparato per processare un materiale flessibile.
IL291531A (en) A method for activating a cell
SG11202106014QA (en) A method for treating lipid materials
DK3543954T3 (da) Fremgangsmåde til behandling af en video
GB2572767B (en) Apparatus for monitoring a measurand
IL280423A (en) A method for identifying protein intermediates
DK3710223T3 (da) Fremgangsmåde til styring af en maskine til forarbejdning af kunststoffer
DK3530560T3 (da) Apparat til overvågning af et bådedrev
DK3741701T3 (da) Fremgangsmåde til fremstilling af et metallisk dåselåg
PL3880834T3 (pl) Metoda przetwarzania pofermentu z biomasy
DK3553212T3 (da) Fremgangsmåde til fremstilling af en krystal af granattypen
AU2024202616A1 (en) Method Of Using A GIP/GLP1 Co-Agonist For Diabetes
GB201813730D0 (en) A method
GB201809530D0 (en) A method
GB201808039D0 (en) A method